Leishmania might be vulnerable to a common anticancer drug
The breast cancer drug tamoxifen kills the single-celled
parasite known as leishmania, a scourge common in the tropics, Brazilian
scientists report. While the tests in mice are preliminary, the finding is heartening
because few good treatments for leishmaniasis exist, says Silvia Uliana, a
physician at the
Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.